FDA says Avastin no longer should be breast cancer drug
The controversial and expensive cancer drug Avastin may be losing its FDA approval for treating breast cancer.

FDA To Revoke Approval Of Avastin For Breast Cancer
On Thursday, FDA announced it will revoke approval of the drug Avastin to treat metastatic breast cancer after several studies suggested the drug does not extend women's lives and carries significant risks, the Washington Post reports. The agency said Genentech, the maker of Avastin and a subsidiary of Roche, has 15 days to request a hearing to review the decision. The company in a statement ...

Cephalon Ends Bid To Get FDA Approval On Nuvigil For Jet Lag
Cephalon Ends Bid To Get FDA Approval On Nuvigil For Jet Lag